A detailed history of Fmr LLC transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Fmr LLC holds 1,094,848 shares of CORT stock, worth $65.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,094,848
Previous 852,345 28.45%
Holding current value
$65.3 Million
Previous $21.5 Million 65.68%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$22.21 - $34.48 $5.39 Million - $8.36 Million
242,503 Added 28.45%
1,094,848 $35.6 Million
Q1 2024

May 13, 2024

BUY
$21.1 - $27.46 $2.97 Million - $3.87 Million
140,940 Added 19.81%
852,345 $21.5 Million
Q4 2023

Feb 13, 2024

BUY
$24.82 - $32.88 $682,078 - $903,575
27,481 Added 4.02%
711,405 $23.1 Million
Q3 2023

Nov 13, 2023

BUY
$21.97 - $33.8 $7.6 Million - $11.7 Million
346,000 Added 102.39%
683,924 $18.6 Million
Q2 2023

Aug 11, 2023

BUY
$21.44 - $25.15 $4.28 Million - $5.02 Million
199,755 Added 144.57%
337,924 $7.52 Million
Q1 2023

May 11, 2023

BUY
$19.2 - $24.47 $140,371 - $178,900
7,311 Added 5.59%
138,169 $2.99 Million
Q4 2022

Feb 13, 2023

SELL
$19.95 - $29.96 $1.98 Million - $2.98 Million
-99,306 Reduced 43.15%
130,858 $2.66 Million
Q3 2022

Nov 10, 2022

BUY
$24.7 - $29.12 $4.2 Million - $4.95 Million
169,899 Added 281.92%
230,164 $5.9 Million
Q2 2022

Aug 12, 2022

SELL
$17.33 - $25.3 $4,349 - $6,350
-251 Reduced 0.41%
60,265 $1.43 Million
Q1 2022

May 13, 2022

BUY
$16.53 - $25.21 $871,577 - $1.33 Million
52,727 Added 676.94%
60,516 $1.36 Million
Q4 2021

Feb 14, 2022

SELL
$17.1 - $23.34 $770,047 - $1.05 Million
-45,032 Reduced 85.25%
7,789 $155,000
Q3 2021

Nov 15, 2021

SELL
$19.68 - $22.53 $3,739 - $4,280
-190 Reduced 0.36%
52,821 $1.04 Million
Q2 2021

Aug 13, 2021

BUY
$19.97 - $24.43 $1.06 Million - $1.3 Million
53,011 New
53,011 $1.17 Million

Others Institutions Holding CORT

About CORCEPT THERAPEUTICS INC


  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $6.38B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Fmr LLC Portfolio

Follow Fmr LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.